Infensa Bioscience
PrivateLast Round
Grant
Oct 7, 2024
Total Funding Raised
$27.66M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Infensa Bioscience operates in Healthcare & Life Sciences and is based in Woolloongabba. Its latest recorded funding round was a Grant round in October 2024.
Infensa Bioscience is a biotechnology company that develops peptide-based therapeutic candidates to reduce mortality and morbidity associated with heart attacks and strokes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Infensa Bioscience Comparables
Compare Infensa Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Neurexis Therapeutics | 80% | |
| Forcefield Therapeutics | 79% | |
| NoNO Inc. | 78% |
For institutional investors. Book with your work email.
Infensa Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 7, 2024 | ||||
| Series A | Jul 4, 2022 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 1811% from 47 to 898.
- Oct 7, 2024
$12.1M grant received from health-gov.
For institutional investors. Book with your work email.
Infensa Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Infensa Bioscience's valuation, stock price, and market status.
Is Infensa Bioscience a public or private company?
Infensa Bioscience is a private company.
What is the current stock price of Infensa Bioscience?
Infensa Bioscience is a private company, so its shares have no public market price. Caplight tracks Infensa Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Infensa Bioscience worth (valuation)?
Valuation information for Infensa Bioscience is not publicly available.
Can I buy Infensa Bioscience stock?
Infensa Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Infensa Bioscience's last funding round?
Infensa Bioscience's most recent funding round was Grant on October 7, 2024.
Who are the main investors in Infensa Bioscience?
Investor information for Infensa Bioscience is not publicly disclosed.
Will Infensa Bioscience IPO soon?
No public IPO plans have been announced for Infensa Bioscience.
How can I track Infensa Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Infensa Bioscience's shares on secondary markets.